Dapagliflozin-Mepha 5 mg, Filmtabletten - 28 Swissmedic Key 69915001 Registration Holder Mepha Pharma AG Name Dapagliflozin-Mepha 5 mg, Filmtabletten Date of registration 09.04.2025 Introduction of Sequence 09.04.2025 ATC-Classification Dapagliflozin (A10BK01) Revision date WHO WHO-DDD Valid until 08.04.2030 Index Therapeuticus (BSV) Show package size 28 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680699150014 Medication Code Synthetika Pharmacode Disponibility
Composition dapagliflozinum 5 mg, cellulosum microcristallinum, lactosum 25 mg, crospovidonum, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: natrii laurilsulfas, poly(alcohol vinylicus), macrogolum 3350, E 171, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 0.263 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dapagliflozinum 5 mg
Inactive agents Dose additional_information (Flavum) Cellulosum Microcristallinum Crospovidonum E 171 color. E 172 color. Lactosum 25 mg Macrogol 3350 Natrii Laurilsulfas Überzug Natrii Stearylis Fumaras Poly(Alcohol Vinylicus) Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 07.05.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
